Antimicrobial activity, pharmacokinetics and clinical studies of balofloxacin (Q-35) in obstetrics and gynaecology.
Cho
N
N
Department of Obstetrics and Gynecology, Showa University, Fujigaoka Hospital, Yokohama, Japan.
Miyakawa
Z
Z
Kimura
T
T
Shimizu
A
A
Notake
Y
Y
Kunii
K
K
D000328:Adult; D000890:Anti-Infective Agents / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D005260:Female; D024841:Fluoroquinolones; D005831:Genital Diseases, Female / Q000188:drug therapy* / Q000382:microbiology; D006094:Gram-Positive Bacteria / Q000187:drug effects; D006801:Humans; D008826:Microbial Sensitivity Tests; D011645:Puerperal Infection / Q000188:drug therapy* / Q000382:microbiology; D015363:Quinolones / Q000493:pharmacokinetics* / Q000494:pharmacology / Q000627:therapeutic use*; D014599:Uterus / Q000378:metabolism
D000890:Anti-Infective Agents; D024841:Fluoroquinolones; D015363:Quinolones; C077155:balofloxacin